Invesco Funds - Invesco China Health Care Equity Fund C CNH Acc
ISIN LU2243644825 / Valor 58250921
Invesco Funds - Invesco China Health Care Equity Fund C CNH Acc
UMushroom community rating:
General Objective
The fund aims to achieve long-term capital growth by investing primarily in a concentrated portfolio of Chinese healthcare companies listed on the Shanghai or Shenzhen Stock Exchanges, traded via Stock Connect, or listed or traded elsewhere via Qualified foreign investor(s) (QFI). Up to 30% of the NAV of the Fund may be exposed to China-A shares via QFI.
Fund Exposure
The fund is characterized by its exposure to Chinese healthcare companies, with a focus on CROs, CDMOs, and pharmaceutical companies with strong pipelines of innovative drugs. The fund also looks at both large market leaders and small to medium-sized companies in the sector, emphasizing industry leadership, competitive advantages, clear business strategies, and transparent corporate governance.
Risks
Investors should be aware that the value of investments and any income may fluctuate, partly due to exchange rate fluctuations. As the fund is invested in less developed countries and a particular sector, investors should be prepared for significantly large fluctuations in the value of the fund. Additionally, the fund's investment in certain securities listed in China may involve significant regulatory constraints that could affect liquidity and investment performance.
Source
https://www.invesco.com/de/de/financial-products/sicav/invesco-china-health-care-equity-fund.html
Ratings & reviews
OTHER SHARE CLASSES OF THIS FUND
